Skip to main content
. 2022 Jun 14;22:213. doi: 10.1186/s12935-022-02622-x

Fig. 9.

Fig. 9

Correlations between THBS2 expression and ImmuneScore/StromalScore in cancers. a Correlation between THBS2 expression and ImmuneScore was identified in adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), esophageal carcinoma (ESCA), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), head and neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIRC), kidney chromophobe (KICH), liver hepatocellular carcinoma (LIHC), kidney renal papillary cell carcinoma (KIRP), ovarian serous cystadenocarcinoma (OV), mesothelioma (MESO), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), rectal adenocarcinoma (READ), pheochromocytoma and paraganglioma (PCPG), prostate adenocarcinoma (PRAD), sarcoma (SARC), skin cutaneous melanoma (SKCM), pancreatic adenocarcinoma (PAAD), uterine corpus endometrial carcinoma (UCEC), thyroid carcinoma (THCA), uterine carcinosarcoma (UCS), testicular germ cell tumors (TGCT), uveal melanoma (UVM), and stomach adenocarcinoma (STAD). b Correlations between THBS2 expression and StromalScore were identified in BLCA, BRCA, LIHC, COAD, KIRC, KICH, PRAD, PCPG, PAAD, OV, LUSC, LUAD, SARC, READ, UCEC, THCA, STAD, SKCM, and UVM